BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32376689)

  • 1. Androgen attenuates the inactivating phospho-Ser-127 modification of yes-associated protein 1 (YAP1) and promotes YAP1 nuclear abundance and activity.
    Cinar B; Al-Mathkour MM; Khan SA; Moreno CS
    J Biol Chem; 2020 Jun; 295(25):8550-8559. PubMed ID: 32376689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.
    Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B
    J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP.
    Seo WI; Park S; Gwak J; Ju BG; Chung JI; Kang PM; Oh S
    Biochem Biophys Res Commun; 2017 May; 486(4):1034-1039. PubMed ID: 28366633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress kinase signaling regulates androgen receptor phosphorylation, transcription, and localization.
    Gioeli D; Black BE; Gordon V; Spencer A; Kesler CT; Eblen ST; Paschal BM; Weber MJ
    Mol Endocrinol; 2006 Mar; 20(3):503-15. PubMed ID: 16282370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FFAR1-and FFAR4-dependent activation of Hippo pathway mediates DHA-induced apoptosis of androgen-independent prostate cancer cells.
    Wang J; Hong Y; Shao S; Zhang K; Hong W
    Biochem Biophys Res Commun; 2018 Nov; 506(3):590-596. PubMed ID: 30366669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers.
    Marx A; Schumann A; Höflmayer D; Bady E; Hube-Magg C; Möller K; Tsourlakis MC; Steurer S; Büscheck F; Eichenauer T; Clauditz TS; Graefen M; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Haese A; Schlomm T; Bernreuther C; Lebok P; Polonski A
    Sci Rep; 2020 Jun; 10(1):8916. PubMed ID: 32488048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility.
    Al-Mathkour MM; Dwead AM; Alp E; Boston AM; Cinar B
    Sci Rep; 2022 Mar; 12(1):3840. PubMed ID: 35264657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications.
    Bhardwaj A; Singh S; Srivastava SK; Honkanen RE; Reed E; Singh AP
    Mol Cancer Ther; 2011 May; 10(5):720-31. PubMed ID: 21393425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor phosphorylation and activity are regulated by an association with protein phosphatase 1.
    Chen S; Kesler CT; Paschal BM; Balk SP
    J Biol Chem; 2009 Sep; 284(38):25576-84. PubMed ID: 19622840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yes-Associated Protein 1 Is a Novel Calcium Sensing Receptor Target in Human Parathyroid Tumors.
    Tavanti GS; Verdelli C; Morotti A; Maroni P; Guarnieri V; Scillitani A; Silipigni R; Guerneri S; Maggiore R; Mari G; Vicentini L; Dalino Ciaramella P; Vaira V; Corbetta S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells.
    Collak FK; Demir U; Sagir F
    Pathol Oncol Res; 2020 Apr; 26(2):867-876. PubMed ID: 30859486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of HSP90 by protein kinase A is essential for the nuclear translocation of androgen receptor.
    Dagar M; Singh JP; Dagar G; Tyagi RK; Bagchi G
    J Biol Chem; 2019 May; 294(22):8699-8710. PubMed ID: 30992362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Human Adenovirus Type 5 E4orf4 Protein Targets Two Phosphatase Regulators of the Hippo Signaling Pathway.
    Mui MZ; Zhou Y; Blanchette P; Chughtai N; Knight JF; Gruosso T; Papadakis AI; Huang S; Park M; Gingras AC; Branton PE
    J Virol; 2015 Sep; 89(17):8855-70. PubMed ID: 26085163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis.
    Subramaniam D; Ponnurangam S; Ramalingam S; Kwatra D; Dandawate P; Weir SJ; Umar S; Jensen RA; Anant S
    Cells; 2021 Jun; 10(7):. PubMed ID: 34206989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
    Guo C; Wang X; Liang L
    Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP1 and AR interactions contribute to the switch from androgen-dependent to castration-resistant growth in prostate cancer.
    Kuser-Abali G; Alptekin A; Lewis M; Garraway IP; Cinar B
    Nat Commun; 2015 Sep; 6():8126. PubMed ID: 28230103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.